AI, Polygenic Risk Scores, and Antithrombotic...

Dr. Carolyn Lam and Dr. Harlan Krumholz sit down with Dr. Rishi Wadhera to unpack the first-ever JACC Cardiovascular Statistics issue. They explore why this annual report matters, the key trends in U.S. cardiovascular health, and what clinicians should take away about hypertensio ...  Show more

In this episode of JACC This Week, Dr. Carolyn Lam and Dr. Harlan Krumholz spotlight a mini-focus issue on hypertrophic cardiomyopathy (HCM), a field undergoing rapid transformation. The discussion centers on the MAPLE-HCM trial comparing aficamten and metoprolol in symptomatic o ...  Show more

More from ESC including: Valvular HD guidelines, a new drug class for HTN, myosin inhibition in HCM, vericiguat, and digoxin are the topic discussed by John Mandrola, MD. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit ...  Show more

The SMART-CHOICE 3 trial demonstrated that clopidogrel monotherapy is more effective than aspirin monotherapy in reducing the risk of major adverse cardiac and cerebrovascular events in high-risk patients who completed standard dual antiplatelet therapy (DAPT) following percutane ...  Show more

Following the European Society of Cardiology's (ESC) guidelines publication in collaboration with EACTS, Miia L Lehtinen and Can Gollmann-Tepeköylü host the esteemed Atrial Fibrillation experts, Manuel Castella and Niv Ad. In this month's episode, our guests explore the nuance ...

In this episode of Spoonful of Sugar, host Eishan Ashwat, a medical student at the University of Pittsburgh, dives into the essential yet often life-threatening topics of aortic aneurysms and dissections. Starting with a clinical vignette to set the stage, Eishan explores the ana ...  Show more